ICI PHOSFONE 50 E EMULSIFIABLE CONCENTRATE INSECTICIDE

Main information

  • Trade name:
  • ICI PHOSFONE 50 E EMULSIFIABLE CONCENTRATE INSECTICIDE
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ICI PHOSFONE 50 E EMULSIFIABLE CONCENTRATE INSECTICIDE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CITRUS FRUIT OR TREE | GRAPEVINE | HOME GARDEN USE - GENERAL | POME FRUIT | STONE FRUIT | TOBACCO | VEGETABLE | APPLE | APRICOT
  • Therapeutic area:
  • INSECTICIDE
  • Therapeutic indications:
  • APHID | BLACK CITRUS APHID | BLACK PEACH APHID | BRYOBIA MITE | CHERRY APHID | CITRUS RUST MITE OR MAORI MITE | CODLING MOTH | EUROPEAN RED MITE | GENERAL WEED - SEE LABEL | GRAPELEAF BLISTER MITE | GREEN PEACH APHID | MEALY BUG | MITE | OYSTERSHELL SCALE | PEARLEAF BLISTER MITE | RED SPIDER MITE | SAN JOSE' SCALE | SCALE | THRIP | TOBACCO LOOPER OR LOOPER CATERPILLAR | WOOLLY APHID | BARNYARD GRASS | BLACK CHERRY APHID | BLADY GRASS | BROME GRASS | BUFFALO GRASS | CHERRY BLACKFLY | COUCH GRASS | DANDELION | DIASPIDIOTUS OSTREAEFORMIS | DIASPIDIOTUS PERNICIOSUS | ERIOPHYES PYRI | FLATWEED | GUINEA GRASS | KIKUYU GRASS | LANTANA | MEALYBUG | NUTGRASS | ONION WEED | OXALIS | PASPALUM | QUADRASPIDIOTUS PERNICIOSUS | RHODES GRASS | RYEGRASS | SORREL | SPIDER MITE | ST JOHN'S WORT | THRIPS SPP. | TOXOPTERA CITRICIDA | VINELEAF BLISTER MITE | WEED CONTROL - GENERAL | WINTER GRASS

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 33064
  • Last update:
  • 09-08-2016

6-12-2018

Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled lots of the product have been found to potentially have higher concentrations of ibuprofen.

FDA - U.S. Food and Drug Administration

18-12-2018


Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Scientific recommendation on classification of advanced therapy medicinal products: Concentrate of autologous bone marrow-derived mononuclear cells (BM-MNC)

Europe - EMA - European Medicines Agency

12-12-2018


Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Scientific recommendation on classification of advanced therapy medicinal products: Autologous concentrated bone marrow

Europe - EMA - European Medicines Agency

2-10-2018

NexoBrid (MediWound Germany GmbH)

NexoBrid (MediWound Germany GmbH)

NexoBrid (Active substance: Concentrate of proteolytic enzymes enriched in bromelain) - PSUSA - Modification - Commission Decision (2018)6460 of Tue, 02 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/10028/201712

Europe -DG Health and Food Safety

19-9-2018

Targretin (Eisai GmbH)

Targretin (Eisai GmbH)

Targretin (Active substance: bexarotene) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)6098 of Wed, 19 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/326/T/50

Europe -DG Health and Food Safety

4-6-2018

Eliquis (Bristol-Myers Squibb/Pfizer EEIG)

Eliquis (Bristol-Myers Squibb/Pfizer EEIG)

Eliquis (Active substance: apixaban) - Centralised - 2-Monthly update - Commission Decision (2018)3616 of Mon, 04 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2148/II/50

Europe -DG Health and Food Safety